StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Shares of NYSE:NAVB opened at $0.00 on Friday. The firm has a market capitalization of $100,084.00, a price-to-earnings ratio of -0.02 and a beta of 1.47. Navidea Biopharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.11.
Navidea Biopharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Navidea Biopharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- The Average 401k Balance by Age Explained
- What is Forex and How Does it Work?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Do ETFs Pay Dividends? What You Need to Know
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.